Medi Caps logo

Medi Caps financials and balance sheet

NSE: MEDICAPQBSE: 523144Pharmaceuticals & BiotechnologySmall Cap

Last close ₹24.95down ₹0.05 (0.20%)BSE ₹25.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹25.00.

52-week range of BSE trades to 23 Oct 2026
₹21.00Low, 11 Mar 2026₹44.70High, 29 Oct 2025
Market cap
₹31 Cr3,735th largest listed
P/E
Lossover the last 12 months
P/B
0.3
Dividend yield
Nonein the last 12 months
ROE
−1.5%
ROCE
−8.7%
Debt to equity
0.00
Volume, NSE
1,595

10 years at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Medi Caps annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹70 Cr, year to Mar 2022A loss in 4 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue12
  2. Materials and goods−5.6
  3. Employee costs−7.7
  4. Other expenses−8.5
  5. Operating profit−9.4
  6. Depreciation−1.8
  7. Other income+8.2
  8. One-off items0.0
  9. Finance costs0.0
  10. Profit before tax−3.0
  11. Tax0.0
  12. Net profit−3.0

What the company owns

  • Plant, investments and other assets₹82 Cr
  • Current investments₹23 Cr
  • Receivables₹7 Cr
  • Inventory₹3 Cr
  • Cash and bank₹1 Cr

What pays for it: net worth and liabilities

  • Net worth₹112 Cr
  • Other liabilities₹3 Cr
  • Owed to suppliers₹0 Cr

Medi Caps business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Consolidated, ₹ crore, as the company reports them. A segment at a loss has no share of profit.Medi Caps segment results by quarter

Revenue by segment

₹12 CrTotal
  • Pharma Devision₹10.1 Cr81.5% of total
  • Real Estate Devision₹2.3 Cr18.5% of total

Segment results by year

Consolidated, ₹ crore, years to March.

  • Pharma Devision

    Revenue, ₹ crore
    Profit, ₹ crore
  • Real Estate Devision

    Revenue, ₹ crore
    Profit, ₹ crore
  • Other

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue of all businesses––597251282512
Company revenue, as in its results5445597049272512
Revenue––597150212310
Revenue growth–––20.0%−29.4%−59.2%12.4%−56.0%
Profit––11105−6−1−3
Profit growth–––−10.0%−53.9%–––
Margin––19.0%14.2%9.3%−29.6%−4.8%−28.5%
Return on capital––10.7%8.8%4.0%−11.1%−2.0%−6.4%
Assets––114129124595748
Liabilities––9147533
Capital employed––105115117545445
Revenue––011722
––000000
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Consolidated, ₹ crore, years to March.Medi Caps quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 6 JunMar 2020Filed 29 JunMar 2021Filed 25 JunMar 2022Filed 24 JunMar 2023Filed 24 MayMar 2024Filed 25 JulMar 2025Filed 12 JunMar 2026Filed 21 May
Revenue from operations44.850.653.945.358.769.949.427.325.512.4
–47.647.249.946.559.944.327.427.321.9
Materials and goods bought22.627.026.326.829.430.122.99.510.75.6
Employee costs––9.611.06.77.77.77.17.67.7
Other expenses––11.312.110.522.113.710.89.18.5
Operating profit before depreciation–3.06.7−4.612.210.05.10.0−1.8−9.4
Operating margin–5.9%12.5%−10.1%20.7%14.3%10.3%−0.1%−7.2%−75.6%
Materials, % of revenue––48.9%59.2%50.0%43.1%46.4%34.8%41.8%45.3%
Employee costs, % of revenue––17.7%24.4%11.4%11.0%15.6%25.9%29.8%62.2%
Other expenses, % of revenue––20.9%26.6%17.8%31.6%27.8%39.5%35.6%68.1%
Depreciation and amortisation–1.81.81.81.51.81.71.71.71.8
Operating profit after depreciation–1.24.9−6.410.78.13.3−1.7−3.5−11.2
Other income1.30.20.60.60.61.91.60.52.78.2
Finance costs0.00.00.00.00.00.00.00.00.00.0
One-off items0.00.00.00.00.00.00.00.00.00.0
Profit before tax1.71.35.5−5.811.210.14.9−1.2−0.8−3.0
0.40.20.10.00.00.03.11.0−0.30.0
Profit from discontinued businesses––––−0.10.0−0.1–––
Net profit1.41.15.4−5.911.110.11.8−2.2−0.6−3.0
Other comprehensive income––0.01.22.61.50.64.70.9−6.6
Total comprehensive income––5.4−4.613.811.52.32.40.3−9.7
Net margin3.1%2.3%10.0%−12.9%19.0%14.4%3.6%−8.2%−2.2%−24.4%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2018 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Mar 2017: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2019Filed 6 JunMar 2020Filed 29 JunMar 2021Filed 25 JunMar 2022Filed 24 JunMar 2023Filed 24 MayMar 2024Filed 25 JulMar 2025Filed 12 JunMar 2026Filed 21 May
9691105116119121121112
Share capital1212121212121212
Reserves83789210410610910999
00000000
939136533
21111111
Total assets10795115130126127125115
6562626466677268
4233536760605347
Net debt−15−20−33−37−27−30−29−24
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2021Filed 25 JunMar 2022Filed 24 JunMar 2023Filed 24 MayMar 2024Filed 25 JulMar 2025Filed 12 JunMar 2026Filed 21 May
15.37.0−6.16.95.1−7.0
15.37.0−3.07.94.8−6.9
−0.3−6.4−10.22.93.10.9
Receivables−2.0−3.71.6−2.42.01.9
Inventories−1.3−5.14.81.32.50.3
Other working capital3.02.4−16.63.9−1.5−1.2
Tax paid0.00.0−3.1−1.00.30.0
Capital spending0.02.81.20.30.30.8
Free cash flow15.34.2−7.26.64.7−7.9
−9.7−4.1−2.6−7.7−5.07.1
Cash from financing−0.10.00.00.00.00.0
Dividends paid0.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash5.62.9−8.6−0.80.10.1
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Consolidated, ₹ per share, years to March.Medi Caps dividend history

₹ per shareMar 2017Mar 2018Mar 2019Filed 6 JunMar 2020Filed 29 JunMar 2021Filed 25 JunMar 2022Filed 24 JunMar 2023Filed 24 MayMar 2024Filed 25 JulMar 2025Filed 12 JunMar 2026Filed 21 May
Earnings per share₹1.10₹0.92₹4.32––₹8.08₹1.41−₹1.80−₹0.46−₹2.44
Diluted earnings per share₹1.10₹0.92₹4.32––₹8.08₹1.41−₹1.80−₹0.46−₹2.44
Book value per share––₹76.67₹72.94₹83.97₹93.23₹95.09₹97.02₹97.25₹89.50
Shareholder yield––––0.0%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)34.428.720.610.250.361.943.655.351.828.9
Earnings per share is left blank for the years to Mar 2020 and Mar 2021: the earnings per share stated does not match any profit the filing states over the shares in issue, and the share count barely moved during the period.

Ratios

Consolidated, years to March.Medi Caps PE ratio and valuation

RatioMar 2018Mar 2019Filed 6 JunMar 2020Filed 29 JunMar 2021Filed 25 JunMar 2022Filed 24 JunMar 2023Filed 24 MayMar 2024Filed 25 JulMar 2025Filed 12 JunMar 2026Filed 21 May
Revenue growth12.9%6.6%−15.9%29.5%19.0%−29.3%−44.6%−6.8%−51.1%
Operating profit growth–127.4%––−18.2%−49.2%–––
Net profit growth−16.1%369.3%––−9.4%−82.6%–––
Earnings per share growth−16.4%369.6%–––−82.5%–––
–5.6%−6.3%11.4%9.1%1.5%−1.9%−0.5%−2.6%
––−11.9 pts17.6 pts−2.3 pts−7.6 pts−3.4 pts1.4 pts−2.1 pts
From the net margin––−12.9 pts15.5 pts−2.7 pts−6.9 pts−4.9 pts1.4 pts−4.7 pts
From asset turnover––0.8 pts2.3 pts0.2 pts−0.7 pts1.5 pts0.0 pts2.5 pts
From borrowing––0.2 pts−0.1 pts0.3 pts0.0 pts0.1 pts0.0 pts0.0 pts
Return on capital employed–5.2%−7.1%10.2%7.0%2.8%−1.4%−2.9%−10.1%
Cash conversion–––137.6%69.7%−346.4%–––
Interest cover167.9274.3––40,718.02,074.4–––
Debt to equity–0.000.000.000.000.000.000.000.00
Receivable days–8735405363144126203
Inventory days–1527483144113220110190
Payable days–89277714245705431
Cash conversion cycle, days–149834755130294181362
Working capital days–123816488200324304598
Asset turnover–0.510.450.560.570.390.220.200.10
Assets per rupee of net worth–1.121.081.071.111.091.061.041.03
Sales per rupee of plant–0.920.781.962.241.600.930.910.46
Capital spending to depreciation–––0.001.540.670.210.190.47
Plant being built, % of plant in use––0.0%1.8%0.8%0.0%–0.3%0.0%
Interest cover is left blank for the years to Mar 2020, Mar 2025 and Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
−2.5%
Measure10 years5 years3 years
Revenue growth, yearly rate–−26.7%−36.8%
Return on equity, average–1.1%−1.7%
Return on capital employed, average–−0.9%−4.8%
Operating margin, average−3.3%−11.7%−27.6%
Net margin, average0.5%−3.4%−11.6%
Asset turnover, average–0.300.17
Cash conversion cycle, days, average–205279
Debt to equity, average–0.000.00

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations5.95.0−7.0
Cash from investing−12.2−5.67.1
Cash from financing0.00.00.0
Capital spending5.51.50.8
Dividends paid0.00.00.0
Shares bought back0.00.00.0
Shares issued for cash0.00.00.0
Borrowings raised0.00.00.0
Borrowings repaid0.00.00.0

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––743552
Altman Z-scorePublished threshold 1.81––3.263.245.405.035.747.169.376.19
Beneish M-scorePublished threshold −1.78––––23.44−2.19−2.07−2.14−2.67−2.30
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––5.255.828.11−1.14−0.52−2.60
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.710.82––
Receivables growth less revenue growthOur threshold 0 percentage points–––−49.7815.4138.7113.3872.41−11.9129.88
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−52.0213.6774.15−16.4139.59−56.1238.99
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––0.175.052.2720.08−18.20−2.587.31
Assets under construction, years of additionsOur threshold 2 years of additions–––0.00–0.080.00–0.300.00
Effective tax ratePublished threshold 17.16 per cent20.5114.842.12–−0.050.1462.07–––
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––0.14−0.03–––
A threshold marked as ours has no published figure; it is the line we read the check against.